PRESS RELEASE published on 03/05/2025 at 15:52, 9 months 11 days ago Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors Oncodesign Precision Medicine appoints Christophe Thurieau, Executive Director Research at Servier, as an independent member of the Board of Directors for a four-year term. Thurieau brings over 35 years of healthcare expertise to OPM Board Of Directors Healthcare Christophe Thurieau Oncodesign Precision Medicine Servier
BRIEF published on 03/05/2025 at 15:52, 9 months 11 days ago Christophe Thurieau rejoint le Conseil d'Administration d'Oncodesign Precision Medicine Biotechnologie Conseil D'administration Nomination Christophe Thurieau Oncodesign Precision Medicine
BRIEF published on 03/05/2025 at 15:52, 9 months 11 days ago Christophe Thurieau joins the Board of Directors of Oncodesign Precision Medicine Board Of Directors Biotechnology Appointment Christophe Thurieau Oncodesign Precision Medicine
PRESS RELEASE published on 03/05/2025 at 15:47, 9 months 11 days ago Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors Nomination de Christophe Thurieau en tant qu’administrateur indépendant du Conseil d’Administration d’OPM. Christophe Thurieau, expert en Recherche et Développement Pharmaceutique, rejoindra OPM pour un mandat de 4 ans Biopharmaceutique Médecine De Précision Administrateur Indépendant OPM Christophe Thurieau
BRIEF published on 10/15/2024 at 08:05, 1 year 2 months ago OPM-101 Phase 1 Trial Results Presented at UEG Week 2024 Ulcerative Colitis Phase 1 Trial UEG Week 2024 OPM-101 Safety Profile
BRIEF published on 10/15/2024 at 08:05, 1 year 2 months ago Résultats de l'essai de phase 1 OPM-101 présentés à l'UEG Week 2024 Rectocolite Hémorragique Semaine UEG 2024 OPM-101 Essai De Phase 1 Profil De Sécurité
PRESS RELEASE published on 10/15/2024 at 08:00, 1 year 2 months ago Inside Information / Other news releases OPM presents safety & efficacy data on OPM-101, a novel RIPK2 kinase inhibitor, in healthy volunteers at UEG Week 2024 conference, targeting IBD treatment Precision Medicine UEG Week 2024 OPM-101 RIPK2 Kinase Inhibitor IBD Treatment
Published on 12/16/2025 at 23:20, 9 hours 4 minutes ago Tactical Resources Announces Shareholder Approval of Arrangement With Plum Acquisition Corp. III
Published on 12/16/2025 at 23:20, 9 hours 4 minutes ago GMV Minerals Announces Upsize of Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/16/2025 at 23:07, 9 hours 17 minutes ago Linear Minerals Corp Closes First Tranche of Private Placement Financing
Published on 12/16/2025 at 22:20, 10 hours 4 minutes ago NuRAN Announces Intention to Close the Restructuring Transaction and Additional Debt Settlements
Published on 12/17/2025 at 08:00, 24 minutes ago Oversubscribed 16th capital increase for Akara Swiss Diversity Property Fund PK
Published on 12/17/2025 at 08:00, 24 minutes ago 16ème augmentation de capital sursouscrite pour l’Akara Swiss Diversity Property Fund PK
Published on 12/17/2025 at 07:35, 49 minutes ago AFYREN awarded Silver Medal by EcoVadis for CSR performance, ranking in the top 8% worldwide
Published on 12/16/2025 at 21:45, 10 hours 38 minutes ago Mise à disposition du rapport financier annuel
Published on 12/16/2025 at 20:10, 12 hours 14 minutes ago donation of shares of Seval, member of the Feuillet family concert
Published on 12/16/2025 at 20:10, 12 hours 14 minutes ago Donation de titres de la société Seval, membre du concert familial Feuillet
Published on 12/16/2025 at 18:53, 13 hours 31 minutes ago Number of shares and voting rights - November 2025 (In French only)
Published on 12/16/2025 at 18:53, 13 hours 31 minutes ago Nombre total d'actions et droits de vote - novembre 2025